2022-03-04
According to official news, CHAOSMETA's operation project BINSwap will soon log on to the BSC Binance smart chain on March 16. CHAOSMETA is a well-known game chain reform, public chain research and development, asset management, international BEP-998NFT trading platform in Singapore. The login of BINSwap will bring CHAOSMETA a new experience of the digital game metaverse. BionicWorld, one of binswap's games, is a game based on global blockchain technology. At BionicWorld, players will immerse themselves in virtual reality experiences by reclaiming land, cultivating crops, raising pets, building their own homes, harvesting and trading agricultural and sideline products, and collaborating to build farm cooperatives. BionicWorld covers multiple independent ecosystems such as collectibles, games, and e-commerce, with a unique ecosystem and economic model, combining popular elements such as current popular cultivation, GameFi, NFT, metaverse, etc., and continuing to innovate on this basis. BionicWorld aims to provide players with the perfect gaming environment while also providing a source of income for every player. At the same time, BionicWorld will also integrate perfectly with the physical agricultural economy. All the benefits of BINSwap will be presented in the form of the in-game native token BIN.
BINSwap is based on the BSC Binance smart chain developed on-chain wallet + BEP-998NFT protocol + GameFi + social comprehensive blockchain ecological plate (has landed) Users can freely trade digital assets on the platform, minting and storing assets all on-chain automatic execution.

Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map